The global hemodialysis and peritoneal dialysis market size was estimated to be USD 103.44 billion in 2023 and is expected to reach at USD 273.18 billion by 2034 with a CAGR of 9.23% during the forecast period 2024-2034. Surge in prevalence of Acute Kidney Injury (AKI), the scarcity of organ donors, potential risks associated with transplants, growing technological advancements, increasing efforts by major firms to launch cutting-edge services and products, rising prevalence of diabetes resulting in an increase in ERD patients, improper dietary habits, a poor lifestyle of living, a lack of movement, surge in funding & investment by major market players, and increasing introduction of advanced dialysis systems are some of the key factors boosting the market growth.
Increasing introduction of advanced dialysis systems is predicted to boost the market growth during the forecast period. Dialysis is a procedure utilized to eliminate waste substances such as urea and creatinine from the blood due to the inadequate performance of the kidneys, and it is typically essential for individuals dealing with chronic renal failure. Hence, as the need for innovative dialysis equipment rises, manufacturers are concentrating on the advancement of technologically superior devices. For instance, in August 2022, Fresenius Medical Care North America's Renal Therapies Group has introduced Speedswap, a fresh choice for the NxStage System One with NxView, allowing for the replacement of a dialysis filter with restricted flow without having to replace the entire cartridge.
By product, service was the highest revenue-grossing segment in the global hemodialysis and peritoneal dialysis market in 2023 owing to surge in number of dialysis service providers, growing prevalence of ESRD, and a number of significant dialysis service providers are aiming to diversify their service portfolios by opening and acquiring new dialysis facilities. For instance, in April 2023, Medtronic plc and DaVita have jointly introduced Mozarc Medical, a new independent company dedicated to transforming kidney healthcare and advancing patient-focused technological solutions. Additionally, consumables is predicted to grow at fastest CAGR during the forecast period owing to the increasing investments by government bodies to enhance patient safety, effectiveness, & patient-centered care, growing focus on developing catheters manufactured of high-tech materials that can withstand chemicals including alcohol, peroxides, & iodine, and rising demand for antimicrobial-coated catheters.
By type, hemodialysis was the highest revenue-grossing segment in the global hemodialysis and peritoneal dialysis market in 2023 owing to the growing number of ESRD patients, increase in the number of elderly people with kidney disorders, and growing prevalence of diabetes & hypertension. Additionally, peritoneal dialysis is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of PD treatment procedures, increased emphasis on improving industrial capacity, rising introduction of advanced PD products, and growing investment by major market players for the development of advanced technologies. For instance, in February 2023, The National Kidney Foundation (NKF) has revealed its latest investment through its Innovation Fund, a philanthropic impact investment initiative. This investment is being directed towards Relavo, a company led by female founders, with a mission to enhance the accessibility of home dialysis. Relavo will use this investment to advance the development of its PeritoneX technology, aimed at enhancing the safety of peritoneal dialysis (PD) for patients.
By indication, end-stage renal disease (ESRD) was the highest revenue-grossing segment in the global hemodialysis and peritoneal dialysis market in 2023 owing to the increasing demand for invisible braces, growing prevalence of ESRD, rising awareness regarding the benefits associated with home peritoneal dialysis, and surge in adoption of dialysis products among ESRD patients. Additionally, acute kidney injury (AKI) is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of adult populations with AKI, growing rate of dialysis procedures, rising technological advancements, and increasing funding from major market players. For instance, in April 2023, Dr. Andrea Conroy, a PhD holder and assistant professor in the Department of Pediatrics at the Herman B Wells Center for Pediatric Research at Indiana University School of Medicine, has secured a substantial grant from the National Institute of Allergy and Infectious Diseases. This grant will support her efforts to conduct advanced research on acute kidney injury in children suffering from severe malaria. She plans to initiate a multi-site prospective study involving three hospitals located in Uganda.
By end-user, hospital-based was the highest revenue-grossing segment in the global hemodialysis and peritoneal dialysis market in 2023 owing to the substantial availability of skilled and professional medical staff in hospitals, rising concentration on development of autonomous dialysis centers, high patient uptake for in-center dialysis therapy, increasing focus on the development of novel hemodialysis machines employing a range of techniques. Additionally, home-based is predicted to grow at fastest CAGR during the forecast period owing to the better quality of life, reduced travel expenses, adaptability, & simpler patient mobility, rise in elderly people with various renal dysfunctions choosing home dialysis therapy, increasing development of more convenient blood tubing & dialyzer connections, as well as smaller, bedside-sized dialysis equipment. For instance, in June 2023, AWAK Technologies (AWAK) and Singapore General Hospital (SGH) have commenced a pre-pivotal clinical trial by enrolling their inaugural participant. The trial aims to assess the safety and effectiveness of an enhanced Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising investment by private & government bodies for the development of innovative medical devices, increasing reimbursement policies, growing prevalence of chronic kidney diseases (CKD), presence of major market players, surge in demand for dialysis procedures, and rising launch of advanced devices by market players. For instance, in March 2022, Nipro Medical Corporation, a prominent manufacturer and provider of renal, vascular, and medical-surgical equipment, has introduced the SURDIAL DX Hemodialysis System for commercial use in the United States. SURDIAL DX is an advanced hemodialysis system designed to offer both patients and doctors an optimal experience during dialysis treatment. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of kidney failure, increasing geriatric population, surge in prevalence of diabetes leading to kidney disorders, rising awareness initiatives regarding CKD, growing focus on the development of technologically enhanced products, and increasing approvals by regulatory bodies. For instance, in September 2022, Terumo Corporation has disclosed that WEGO Terumo (Weihai) Medical Products CO., Ltd, a collaborative venture between medical device firm WEGO and Terumo located in China, has secured regulatory clearance from the National Medical Products Administration (NMPA) to produce and distribute a new neutral peritoneal dialysis solution. This innovative product is scheduled for release in early 2023, marking the first availability of a neutralized peritoneal dialysis solution in the Chinese market.
Increasing introduction of advanced dialysis systems is predicted to boost the market growth during the forecast period. Dialysis is a procedure utilized to eliminate waste substances such as urea and creatinine from the blood due to the inadequate performance of the kidneys, and it is typically essential for individuals dealing with chronic renal failure. Hence, as the need for innovative dialysis equipment rises, manufacturers are concentrating on the advancement of technologically superior devices. For instance, in August 2022, Fresenius Medical Care North America's Renal Therapies Group has introduced Speedswap, a fresh choice for the NxStage System One with NxView, allowing for the replacement of a dialysis filter with restricted flow without having to replace the entire cartridge.
By product, service was the highest revenue-grossing segment in the global hemodialysis and peritoneal dialysis market in 2023 owing to surge in number of dialysis service providers, growing prevalence of ESRD, and a number of significant dialysis service providers are aiming to diversify their service portfolios by opening and acquiring new dialysis facilities. For instance, in April 2023, Medtronic plc and DaVita have jointly introduced Mozarc Medical, a new independent company dedicated to transforming kidney healthcare and advancing patient-focused technological solutions. Additionally, consumables is predicted to grow at fastest CAGR during the forecast period owing to the increasing investments by government bodies to enhance patient safety, effectiveness, & patient-centered care, growing focus on developing catheters manufactured of high-tech materials that can withstand chemicals including alcohol, peroxides, & iodine, and rising demand for antimicrobial-coated catheters.
By type, hemodialysis was the highest revenue-grossing segment in the global hemodialysis and peritoneal dialysis market in 2023 owing to the growing number of ESRD patients, increase in the number of elderly people with kidney disorders, and growing prevalence of diabetes & hypertension. Additionally, peritoneal dialysis is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of PD treatment procedures, increased emphasis on improving industrial capacity, rising introduction of advanced PD products, and growing investment by major market players for the development of advanced technologies. For instance, in February 2023, The National Kidney Foundation (NKF) has revealed its latest investment through its Innovation Fund, a philanthropic impact investment initiative. This investment is being directed towards Relavo, a company led by female founders, with a mission to enhance the accessibility of home dialysis. Relavo will use this investment to advance the development of its PeritoneX technology, aimed at enhancing the safety of peritoneal dialysis (PD) for patients.
By indication, end-stage renal disease (ESRD) was the highest revenue-grossing segment in the global hemodialysis and peritoneal dialysis market in 2023 owing to the increasing demand for invisible braces, growing prevalence of ESRD, rising awareness regarding the benefits associated with home peritoneal dialysis, and surge in adoption of dialysis products among ESRD patients. Additionally, acute kidney injury (AKI) is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of adult populations with AKI, growing rate of dialysis procedures, rising technological advancements, and increasing funding from major market players. For instance, in April 2023, Dr. Andrea Conroy, a PhD holder and assistant professor in the Department of Pediatrics at the Herman B Wells Center for Pediatric Research at Indiana University School of Medicine, has secured a substantial grant from the National Institute of Allergy and Infectious Diseases. This grant will support her efforts to conduct advanced research on acute kidney injury in children suffering from severe malaria. She plans to initiate a multi-site prospective study involving three hospitals located in Uganda.
By end-user, hospital-based was the highest revenue-grossing segment in the global hemodialysis and peritoneal dialysis market in 2023 owing to the substantial availability of skilled and professional medical staff in hospitals, rising concentration on development of autonomous dialysis centers, high patient uptake for in-center dialysis therapy, increasing focus on the development of novel hemodialysis machines employing a range of techniques. Additionally, home-based is predicted to grow at fastest CAGR during the forecast period owing to the better quality of life, reduced travel expenses, adaptability, & simpler patient mobility, rise in elderly people with various renal dysfunctions choosing home dialysis therapy, increasing development of more convenient blood tubing & dialyzer connections, as well as smaller, bedside-sized dialysis equipment. For instance, in June 2023, AWAK Technologies (AWAK) and Singapore General Hospital (SGH) have commenced a pre-pivotal clinical trial by enrolling their inaugural participant. The trial aims to assess the safety and effectiveness of an enhanced Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising investment by private & government bodies for the development of innovative medical devices, increasing reimbursement policies, growing prevalence of chronic kidney diseases (CKD), presence of major market players, surge in demand for dialysis procedures, and rising launch of advanced devices by market players. For instance, in March 2022, Nipro Medical Corporation, a prominent manufacturer and provider of renal, vascular, and medical-surgical equipment, has introduced the SURDIAL DX Hemodialysis System for commercial use in the United States. SURDIAL DX is an advanced hemodialysis system designed to offer both patients and doctors an optimal experience during dialysis treatment. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of kidney failure, increasing geriatric population, surge in prevalence of diabetes leading to kidney disorders, rising awareness initiatives regarding CKD, growing focus on the development of technologically enhanced products, and increasing approvals by regulatory bodies. For instance, in September 2022, Terumo Corporation has disclosed that WEGO Terumo (Weihai) Medical Products CO., Ltd, a collaborative venture between medical device firm WEGO and Terumo located in China, has secured regulatory clearance from the National Medical Products Administration (NMPA) to produce and distribute a new neutral peritoneal dialysis solution. This innovative product is scheduled for release in early 2023, marking the first availability of a neutralized peritoneal dialysis solution in the Chinese market.
Segmentation: Hemodialysis and Peritoneal Dialysis Market Report 2022 - 2033
Hemodialysis and Peritoneal Dialysis Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Consumables
- Concentrates
- Catheters
- Bloodline
- Others
- Device
- Dialyzer
- Machine
- Water Treatment System
- Others
- Service
Hemodialysis and Peritoneal Dialysis Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Peritoneal Dialysis
- Automated Peritoneal Dialysis (APD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Hemodialysis
- Short Daily Hemodialysis
- Conventional Hemodialysis
- Nocturnal Hemodialysis
Hemodialysis and Peritoneal Dialysis Market Analysis & Forecast by Indication 2023 - 2034 (Revenue USD Bn)
- Septic Shock
- End-Stage Renal Disease (ESRD)
- Acute Kidney Injury (AKI)
- Multi-Organ Failure
- Others
Hemodialysis and Peritoneal Dialysis Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospital-Based
- Home-Based
Hemodialysis and Peritoneal Dialysis Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Hemodialysis and Peritoneal Dialysis Market: Product Estimates & Trend Analysis
8. Hemodialysis and Peritoneal Dialysis Market: Type Estimates & Trend Analysis
9. Hemodialysis and Peritoneal Dialysis Market: Indication Estimates & Trend Analysis
10. Hemodialysis and Peritoneal Dialysis Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Hemodialysis and Peritoneal Dialysis Market
13. Europe Global Hemodialysis and Peritoneal Dialysis Market
14. Asia Pacific Global Hemodialysis and Peritoneal Dialysis Market
15. Latin America Global Hemodialysis and Peritoneal Dialysis Market
16. MEA Global Hemodialysis and Peritoneal Dialysis Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Dialife SA
- Becton
- Dickinson and Company
- Terumo Corporation
- Asahi Kasei Medical Co. Ltd.
- Baxter International Inc.
- B. Braun Melsungen AG
- Nipro Corporation
- MEDTRONIC PUBLIC LIMITED COMPANY
- Fresenius Medical Care AG & Co. KGaA
- Toray Industries Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 103.44 Billion |
| Forecasted Market Value ( USD | $ 273.18 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
